Phantosmia Phantom Smells Understanding Management

Phantosmia: Phantom Smells, Current Understanding and Management

Phantosmia, the perception of an odor without an external source, is a complex sensory error that can significantly impact quality of life and, in severe cases, physical health. Recent case reports highlight the diverse origins of phantom smells and their profound consequences, offering insights into the brain’s flawed interpretation of smell.

Migraine Brain Activity Can Generate Foul Olfactory Hallucinations

An 18-year-old woman presented at Istanbul Gelisim University with significant weight loss after experiencing phantom odors of rotting material and burnt plastic for up to 12 hours at a time, followed by severe throbbing headaches. Neurologists Mustafa Servet Erdöl, Esra Utku Özçelik, and Betül Baykan identified this as an extremely rare olfactory aura preceding a migraine attack. Her brain MRI showed only minor, non-specific changes, and an electroencephalogram was normal, suggesting the phantom smell originated from transient cortical electrical activity, not a structural brain lesion. The patient’s symptoms responded well to treatment with lamotrigine, an anticonvulsant that stabilizes neuronal membranes. This case confirms that migraine pathophysiology can directly generate false sensory information in the olfactory cortex.

A Psychiatric Disorder Focused on Imagined Body Odor

A 50-year-old man treated at Addis Ababa University was convinced his nose emitted a foul, “dead mouse” odor, a condition known as Olfactory Reference Syndrome (ORS). Psychiatrist Haileleul Mekonnen Tilinty classified ORS as an obsessive-compulsive related disorder. Despite normal otorhinolaryngology exams, the patient engaged in compulsive nasal cleansing and avoided social contact, which ended his marriage. His conviction in the phantom smell persisted despite objective evidence to the contrary, distinguishing ORS from neurological phantosmia. Treatment required a multimodal psychiatric approach: the SSRI antidepressant fluoxetine was titrated to 60 mg daily, augmented with 2 mg of the antipsychotic risperidone at night, combined with cognitive-behavioral therapy. Over a year, his preoccupation and related depression improved markedly.

Differential Diagnosis Separates Brain, Nose, and Mind

These two reports underscore the critical need for accurate differential diagnosis. The pathway for a patient presenting with phantom smells should systematically exclude three areas. First, otorhinolaryngology evaluation rules out local causes like sinusitis or nasal polyps. Second, neurology investigates central causes with tools like MRI and EEG, searching for migraine, epilepsy, or tumors. Third, a psychiatric assessment considers ORS, depression, or psychosis. The Turkish patient’s normal ENT and psych exams pointed to neurology; the Ethiopian patient’s normal ENT and neuro workup pointed to psychiatry. Misdiagnosis leads to ineffective treatment and prolonged suffering. Both cases also highlight that the content of the phantom smell—overwhelmingly foul and unpleasant—is a common feature that adds to patient distress.

Implications for Fragrance Professionals and Product Development

For perfumers and fragrance chemists, phantosmia research reinforces several core principles. First, it demonstrates the sheer power of olfactory perception to dictate behavior and well-being, far beyond simple preference. Second, the specific descriptors patients use—”burnt plastic” or “rotting”—can inform the understanding of certain aroma chemicals perceived at abnormal intensities or in isolation. For instance, sulfurous or pyrazine compounds, which in precise dilution contribute to savory or green notes, might be implicated in such distorted perceptions. Ingredients like Thioacetic Acid or Pyrazine are known for their potent, often challenging smells at high concentrations. Formulators should be aware that individual neurological variability means a small subset of users may experience even well-balanced accords as distorted or unpleasant phantoms.

Furthermore, these cases argue for greater awareness outside clinical settings. Customer complaints about a “persistent foul odor” from a product could, in rare instances, be a report of phantosmia rather than a commentary on the formulation itself. While not common, this knowledge can guide more sensitive and investigative customer feedback processes.

Conclusion

Phantosmia is a serious condition with roots in either neurological dysfunction or psychiatric illness, requiring distinct treatment pathways. Effective management relies on precise diagnosis, with treatments ranging from lamotrigine for migraine to fluoxetine and risperidone for ORS. For the fragrance industry, these findings underscore the profound psychological and physiological impact of smell, highlighting the importance of both precise formulation and informed interpretation of sensory feedback.

Sources:
https://pubmed.ncbi.nlm.nih.gov/41777509/
https://pubmed.ncbi.nlm.nih.gov/41612436/
https://pubmed.ncbi.nlm.nih.gov/35356165/